CB
Chetan Bipinchandra Shah IN IN · SEBI (PIT + SAST)
Discover the detailed record of transactions filed by Chetan Bipinchandra Shah. Officer active across 1 companies, notably Senores Pharmaceuticals Limited. Cumulatively, 19 reports have been recorded. The latest transaction was filed on 10 September 2025 — Purchase. Regulator: SEBI (PIT + SAST). All data is accessible without signup.
Declarations 19 total
€3,459 500 shares @ €6.9187
Equity Shares
SEBI:cd99c8f9350396548abca6147c0e083d1e15b82d · 10 Sept 2025
Ideal exit: 7 Jun 2026 (T+270) €3,295 500 shares @ €6.59
Equity Shares
SEBI:8362e1d4ec5459eb6f82e78777017daa57c81466 · 28 Jul 2025
Ideal exit: 24 Apr 2026 (T+270) €3,260 550 shares @ €5.9278
Equity Shares
SEBI:53541579341b8de30b493f48f5c39e738b53a2ba · 12 Mar 2025
Ideal exit: 7 Dec 2025 (T+270) €6,190 1,000 shares @ €6.1902
Equity Shares
SEBI:f05fc458601113af7a1caeeffc280b1ebe0f2b0d · 25 Feb 2025
Ideal exit: 22 Nov 2025 (T+270) €6,043 1,000 shares @ €6.0434
Equity Shares
SEBI:a67b88fe4c917510348b5d47a2e0334b06f51701 · 24 Feb 2025
Ideal exit: 21 Nov 2025 (T+270) €1,712 298 shares @ €5.7446
Equity Shares
SEBI:8a37ba5815d065fa71a88764c78ea252d6eb880a · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270) €115 20 shares @ €5.7457
Equity Shares
SEBI:47cff4f4ca1c115ace3c98d4fab109706e635e00 · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270) €92 16 shares @ €5.7499
Equity Shares
SEBI:ebae9b6f6187390e0aa48d005211ab4dfdc4944d · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270) €264 46 shares @ €5.7482
Equity Shares
SEBI:d8fcc089ae01c7e9f7cedf73d18ed3f28b85bfa4 · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270) €546 95 shares @ €5.7468
Equity Shares
SEBI:2fdb7f19e3ded042a5333a5a0045eda446ae3764 · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270) €213 37 shares @ €5.7472
Equity Shares
SEBI:00f802fa8e4e26c0c6173644b1b8fce58d163926 · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270) €167 29 shares @ €5.7429
Equity Shares
SEBI:e3273cf537cd5c6971c6435c318b4046470cc3d1 · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270) €132 23 shares @ €5.7461
Equity Shares
SEBI:4d6b3a9a1496646fbe6e69a569551a30460e1a4c · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270) €816 142 shares @ €5.7496
Equity Shares
SEBI:b854b0a713063b4511be60394371f54b649080ed · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270) €6 1 shares @ €5.7341
Equity Shares
SEBI:9b13a043530e671e7684d5b34189d866498b75c5 · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270) €195 34 shares @ €5.7412
Equity Shares
SEBI:d357198a78f7a9c3a0a7e0fd6f55cfe23f00fc32 · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270) €57 10 shares @ €5.7429
Equity Shares
SEBI:2e0c59eed7719f8b5310225d72769a93a3c042e9 · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270) €437 76 shares @ €5.7479
Equity Shares
SEBI:5d1aea68b0660b8adb7ae13e15a46fc3a3f63971 · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270) €132 23 shares @ €5.749
Equity Shares
SEBI:f19799f37b91809cf2cc808d6b8e5df1b936f4ec · 19 Feb 2025
Ideal exit: 16 Nov 2025 (T+270)